Alison is an Advanced Nuclear Medicine Technologist with more than 25 years of experience spanning clinical practice, leadership, and research. She holds a Master of Molecular Imaging Technology from The University of Queensland and has advanced expertise in PET/CT, PET/MR, SPECT/CT, BMD, Theranostics, and radiopharmacy.
She is currently based at the Herston Imaging Research Facility and the Royal Brisbane and Women’s Hospital, where she leads the Nuclear Medicine and Bone Mineral Density portfolios, coordinates national multi-centre imaging studies, and contributes to the development and optimisation of PET/CT and PET/MR research protocols.
Alison has a strong record of translating emerging molecular imaging technologies into clinical practice, mentoring junior staff and trainees, and contributing to professional education and governance. Her academic and clinical interests focus on evidence-based imaging, research translation, and advancing patient-centred nuclear medicine care.
NIF is delighted to congratulate its long-term partner, the Australian Epilepsy Project (AEP), on securing $30 million in Australian Government funding through the Medical Research Future Fund. The pr
28 May 2026
The University of Melbourne officially launched a cutting-edge instrument to capture high temporal resolution brain activity in a new facility that is the first of its kind in the southern hemisphere.
08 May 2026
Queenslanders will benefit from faster, sharper and more precise medical imaging with the launch of one of the world’s most advanced MRI scanners at the Herston Imaging Research Facility (HIRF) in B
20 April 2026
A new international agreement will help ensure that advanced imaging data collected from PET/CT and PET/MR in clinical trials can be reliably compared – making it easier for researchers to collabora
30 March 2026